These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23292452)

  • 1. Screening of candidate tumor-suppressor genes in 3p21.3 and investigation of the methylation of gene promoters in oral squamous cell carcinoma.
    Wang K; Ling T; Wu H; Zhang J
    Oncol Rep; 2013 Mar; 29(3):1175-82. PubMed ID: 23292452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
    Zhang J; Ling T; Wu H; Wang K
    J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.
    Nair PN; McArdle L; Cornell J; Cohn SL; Stallings RL
    Cancer Genet Cytogenet; 2007 Apr; 174(2):100-10. PubMed ID: 17452250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
    Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
    Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
    Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mutation and expression of SEMA3B and SEMA3F gene in nasopharyngeal carcinoma].
    Liu XQ; Sun M; Chen HK; Li JX; Pan ZG; Long QX; Wang XZ; Zeng YX
    Ai Zheng; 2003 Jan; 22(1):16-20. PubMed ID: 12561429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of SEMA3B methylation and expression patterns in gastric cancer tissue and cell lines.
    Chen R; Zhuge X; Huang Z; Lu D; Ye X; Chen C; Yu J; Lu G
    Oncol Rep; 2014 Mar; 31(3):1211-8. PubMed ID: 24402303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
    Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
    Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
    Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
    Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas.
    Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
    Oral Oncol; 2011 Aug; 47(8):702-8. PubMed ID: 21697000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas.
    Long NK; Kato K; Yamashita T; Makita H; Toida M; Hatakeyama D; Hara A; Mori H; Shibata T
    Oral Oncol; 2008 Nov; 44(11):1052-8. PubMed ID: 18485791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional repression of DLEC1 associates with the depth of tumor invasion in oral squamous cell carcinoma.
    Chan WH; Chang KP; Yang SW; Yao TC; Ko TY; Lee YS; Tsai CL; Tsai CN
    Oral Oncol; 2010 Dec; 46(12):874-9. PubMed ID: 20952247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B.
    Tomizawa Y; Sekido Y; Kondo M; Gao B; Yokota J; Roche J; Drabkin H; Lerman MI; Gazdar AF; Minna JD
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13954-9. PubMed ID: 11717452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.
    Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F
    Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients.
    Supić G; Kozomara R; Branković-Magić M; Jović N; Magić Z
    Oral Oncol; 2009 Dec; 45(12):1051-7. PubMed ID: 19665921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
    Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
    Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
    Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
    Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors.
    Tischoff I; Markwarth A; Witzigmann H; Uhlmann D; Hauss J; Mirmohammadsadegh A; Wittekind C; Hengge UR; Tannapfel A
    Int J Cancer; 2005 Jul; 115(5):684-9. PubMed ID: 15704097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation.
    Suzuki E; Imoto I; Pimkhaokham A; Nakagawa T; Kamata N; Kozaki KI; Amagasa T; Inazawa J
    Oncogene; 2007 Dec; 26(57):7921-32. PubMed ID: 17599052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.